Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Skin Cancer/Melanoma

When COVID-19 and Cancer Collide: What Nurses Should Know

When COVID-19 and Cancer Collide: What Nurses Should Know

BY BRIELLE BENYON

More for Melanoma: Nurse Discusses Unmet Needs

More for Melanoma: Nurse Discusses Unmet Needs

BY GRACE CHERRY, NP, MSN, RN

Adverse Event Management for BRAF/MEK Inhibitors in Melanoma

Adverse Event Management for BRAF/MEK Inhibitors in Melanoma

BY BRIELLE BENYON

Immune-Related Adverse Events: Know What to Look for and How to Act

Immune-Related Adverse Events: Know What to Look for and How to Act

BY BRIELLE BENYON

FDA Approves Atezolizumab Combo for Advanced Melanoma

FDA Approves Atezolizumab Combo for Advanced Melanoma

BY HANNAH SLATER

Expert Talks Progress, What's Next in Melanoma Treatment

Expert Talks Progress, What's Next in Melanoma Treatment

BY HAYLEY VIRGIL

Neoadjuvant Melanoma Combo Improves RFS in Macroscopic Melanoma

Neoadjuvant Melanoma Combo Improves RFS in Macroscopic Melanoma

BY GINA COLUMBUS

BRAF-Mutant Melanoma Field Continues to Move Forward

BRAF-Mutant Melanoma Field Continues to Move Forward

BY BRITTANY COTE

Dabrafenib/Trametinib Brings Remission-Free Survival Advantage to Melanoma Subset

Dabrafenib/Trametinib Brings Remission-Free Survival Advantage to Melanoma Subset

BY JESSICA HERGERT

FDA Approves New Pembrolizumab Dosing Schedule

FDA Approves New Pembrolizumab Dosing Schedule

BY JASON M. BRODERICK

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.